Dr. John Kellie, Immunogenicity and Biomarkers Group at GlaxoSmithKline (GSK), discusses how he monitors and quantitates masses of whole, intact large molecules for biotherapeutics using the ionKey/MS system and SYNAPT G2-Si mass spec.
Currently loaded videos are 1 through 15 of 99 total videos.